NCT07283653NARecruiting
Dissemination and Implementation of DIGEST™ as an Evidence-based Measurement Tool for Dysphagia: A Randomized Implementation Trial
M.D. Anderson Cancer Center
Start Date
6/1/2025
Completion Date
1/31/2029
Summary
To improve swallowing outcomes in cancer through clinical implementation of the Dynamic Imaging Grade of Swallowing Toxicity (DIGEST™) as an evidence-based practice (EBP) tool to grade pharyngeal dysphagia (difficulty swallowing) as a toxicity of cancer.
Detailed Description
Primary Objective Assess the impact of implementation strategies on clinical adoption (reach) of DIGEST for oncology MBS studies. Secondary Objective Assess the impact of implementation strategies on the fidelity (reliability) of DIGEST adoption for oncology MBS studies
Eligibility Criteria
Age Range: 18 years to No maximum
Inclusion Criteria:
1. A hospital or clinic affiliated with the Veteran's Affairs system, University of Wisconsin system, or Ohio State University system.
2. A minimum average of 10 Modified Barium Swallow (MBS) procedures per month in oncology patients in preceding year.
3. MBS imaging files are recorded and archived as a routine procedure (and accessible to researchers).
Exclusion Criteria:
N/A
Interventions
OTHER
No intervention
OTHER
DIGEST Training Program
OTHER
DIGEST Training + Practice Facilitation
Conditions
DIGESTEvidence Based MeasurementDysphagiaRandomized Implementation
Locations
MD Anderson Cancer Center
Houston, Texas 77030
United States